Blood Glucose Test Strips Market by End-user and Geography - Forecast and Analysis 2021-2025

1 Executive Summary

2 Market Landscape

• 2.1 Market ecosystem
  • Exhibit 01: Parent market
  • Exhibit 02: Market characteristics

• 2.2 Value chain analysis
  • Exhibit 03: Value Chain Analysis: Healthcare Supplies

3 Market Sizing

• 3.1 Market definition
  • Exhibit 04: Offerings of vendors included in the market definition

• 3.2 Market segment analysis
  • Exhibit 05: Market segments

• 3.3 Market size 2020

• 3.4 Market outlook: Forecast for 2020 - 2025
  • Exhibit 06: Global - Market size and forecast 2020 - 2025 ($ million)
  • Exhibit 07: Global market: Year-over-year growth 2020 - 2025 (%)

4 Five Forces Analysis

• 4.1 Five Forces Summary
  • Exhibit 08: Five forces analysis 2020 & 2025

• 4.2 Bargaining power of buyers
  • Exhibit 09: Bargaining power of buyers

• 4.3 Bargaining power of suppliers
  • Exhibit 10: Bargaining power of suppliers

• 4.4 Threat of new entrants
  • Exhibit 11: Threat of new entrants

• 4.5 Threat of substitutes
  • Exhibit 12: Threat of substitutes

• 4.6 Threat of rivalry
  • Exhibit 13: Threat of rivalry

• 4.7 Market condition
  • Exhibit 14: Market condition - Five forces 2020

5 Market Segmentation by End-user

• 5.1 Market segments

• 5.2 Comparison by End-user

• 5.3 Hospitals and diagnostic laboratories - Market size and forecast 2020-2025

• 5.4 Home care settings - Market size and forecast 2020-2025
  • Exhibit 19: Home care settings - Market size and forecast 2020-2025 ($ million)
  • Exhibit 20: Home care settings - Year-over-year growth 2020-2025 (%)

• 5.5 POL - Market size and forecast 2020-2025
  • Exhibit 21: POL - Market size and forecast 2020-2025 ($ million)
  • Exhibit 22: POL - Year-over-year growth 2020-2025 (%)

• 5.6 Market opportunity by End-user
  • Exhibit 23: Market opportunity by End-user

6 Customer landscape

7 Geographic Landscape

• 7.1 Geographic segmentation
  • Exhibit 25: Market share by geography 2020-2025 (%)

• 7.2 Geographic comparison
  • Exhibit 26: Geographic comparison

• 7.3 North America - Market size and forecast 2020-2025
  • Exhibit 27: North America - Market size and forecast 2020-2025 ($ million)
  • Exhibit 28: North America - Year-over-year growth 2020-2025 (%)

• 7.4 Europe - Market size and forecast 2020-2025
  • Exhibit 29: Europe - Market size and forecast 2020-2025 ($ million)
  • Exhibit 30: Europe - Year-over-year growth 2020-2025 (%)

• 7.5 Asia - Market size and forecast 2020-2025
  • Exhibit 31: Asia - Market size and forecast 2020-2025 ($ million)
  • Exhibit 32: Asia - Year-over-year growth 2020-2025 (%)

• 7.6 ROW - Market size and forecast 2020-2025
  • Exhibit 33: ROW - Market size and forecast 2020-2025 ($ million)
  • Exhibit 34: ROW - Year-over-year growth 2020-2025 (%)

• 7.7 Key leading countries
  • Exhibit 35: Key leading countries

• 7.8 Market opportunity by geography
  • Exhibit 36: Market opportunity by geography ($ million)

8 Drivers, Challenges, and Trends

• 8.1 Market drivers

• 8.2 Market challenges
  • Exhibit 38: Impact of drivers and challenges

• 8.3 Market trends

9 Vendor Landscape

• 9.1 Overview

• 9.2 Vendor landscape
  • Exhibit 39: Vendor landscape

• 9.3 Landscape disruption
  • Exhibit 40: Landscape disruption
  • Exhibit 41: Industry risks

10 Vendor Analysis

• 10.1 Vendors covered
  • Exhibit 42: Vendors covered

• 10.2 Market positioning of vendors
  • Exhibit 43: Market positioning of vendors

• 10.3 Abbott Laboratories
  • Exhibit 44: Abbott Laboratories - Overview
  • Exhibit 45: Abbott Laboratories - Business segments
  • Exhibit 46: Abbott Laboratories – Key news
  • Exhibit 47: Abbott Laboratories - Key offerings
  • Exhibit 48: Abbott Laboratories - Segment focus

• 10.4 Ascensia Diabetes Care Holdings AG

• 10.5 B. Braun Melsungen AG
  • Exhibit 53: B. Braun Melsungen AG - Overview
  • Exhibit 54: B. Braun Melsungen AG - Business segments
  • Exhibit 55: B. Braun Melsungen AG – Key news
  • Exhibit 56: B. Braun Melsungen AG - Key offerings
  • Exhibit 57: B. Braun Melsungen AG - Segment focus

• 10.6 F. Hoffmann-La Roche Ltd.
  • Exhibit 58: F. Hoffmann-La Roche Ltd. - Overview
  • Exhibit 59: F. Hoffmann-La Roche Ltd. - Business segments
  • Exhibit 60: F. Hoffmann-La Roche Ltd. - Key offerings
  • Exhibit 61: F. Hoffmann-La Roche Ltd. - Segment focus

• 10.7 LifeScan IP Holdings LLC
  • Exhibit 62: LifeScan IP Holdings LLC - Overview
  • Exhibit 63: LifeScan IP Holdings LLC - Product and service
  • Exhibit 64: LifeScan IP Holdings LLC - Key offerings

• 10.8 Omnis Health LLC
  • Exhibit 65: Omnis Health LLC - Overview
  • Exhibit 66: Omnis Health LLC - Product and service
  • Exhibit 67: Omnis Health LLC - Key offerings

• 10.9 Sanofi SA
  • Exhibit 68: Sanofi SA - Overview
  • Exhibit 69: Sanofi SA - Business segments
  • Exhibit 70: Sanofi SA - Key offerings
  • Exhibit 71: Sanofi SA - Segment focus

• 10.10 Sinocare Inc.
  • Exhibit 72: Sinocare Inc. - Overview
  • Exhibit 73: Sinocare Inc. - Product and service
  • Exhibit 74: Sinocare Inc. - Key offerings

• 10.11 Teladoc Health Inc.
  • Exhibit 75: Teladoc Health Inc. - Overview
  • Exhibit 76: Teladoc Health Inc. - Business segments
  • Exhibit 77: Teladoc Health Inc. - Key offerings
  • Exhibit 78: Teladoc Health Inc. - Segment focus

• 10.12 UniStrip Technologies LLC
  • Exhibit 79: UniStrip Technologies LLC - Overview
  • Exhibit 80: UniStrip Technologies LLC - Product and service
  • Exhibit 81: UniStrip Technologies LLC - Key offerings

11 Appendix

• 11.1 Scope of the report

• 11.2 Currency conversion rates for US$
  • Exhibit 82: Currency conversion rates for US$

• 11.3 Research methodology
  • Exhibit 83: Research Methodology
  • Exhibit 84: Validation techniques employed for market sizing
  • Exhibit 85: Information sources

• 11.4 List of abbreviations
  • Exhibit 86: List of abbreviations